Iwata, T. N., Sugihara, K., Wada, T., & Agatsuma, T. (2019). [Fam-] trastuzumab deruxtecan (DS-8201a)-induced antitumor immunity is facilitated by the anti–CTLA-4 antibody in a mouse model. PLoS One.
Chicago Style aipamenaIwata, Tomomi Nakayama, Kiyoshi Sugihara, Teiji Wada, and Toshinori Agatsuma. "[Fam-] Trastuzumab Deruxtecan (DS-8201a)-induced Antitumor Immunity Is Facilitated By the Anti–CTLA-4 Antibody in a Mouse Model." PLoS One 2019.
MLA aipamenaIwata, Tomomi Nakayama, Kiyoshi Sugihara, Teiji Wada, and Toshinori Agatsuma. "[Fam-] Trastuzumab Deruxtecan (DS-8201a)-induced Antitumor Immunity Is Facilitated By the Anti–CTLA-4 Antibody in a Mouse Model." PLoS One 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.